At the beginning of the COVID pandemic, doctors and scientists were looking for successful treatments that could decrease the number of victims of the virus. At that point, some promising candidates have emerged, many of whom are already on the market to treat other illnesses. Now, another potential COVID treatment joins the list in the form of a widely available and widely tested inhaler, traditionally used to treat asthma and chronic obstructive pulmonary disease (COPD). According to a new study by the NIHR Oxford Biomedical Research Center (BRC), which has not yet been peer-reviewed, the drug budesonide reduced the risk of serious illness by 90 percent. Read on to learn about this innovative treatment for COVID and for the latest vaccine news, check out Dr. Fauci Says You Will Get A Vaccine Consultation Easily After This Date.
Observing a total of 146 individuals, the researchers gave half the group a budesonide inhaler for twice-daily doses of 800 micrograms, and the other half a placebo for a period of 28 days. Those who took the treatment were not only 90 percent less likely to need urgent care, but they also benefited from shorter periods of fever and fewer long-term symptoms.
“I am encouraged to see a reduction in persistent symptoms at 14 and 28 days after treatment with budesonide”, Mona Bafadhel, MD, a professor and respiratory consultant who also works at the Oxford University Hospitals NHS Foundation Trust, shared on the University of Oxford website. “Persistent symptoms after the initial COVID-19 disease emerged as a long-term problem. Any intervention that could resolve this would be a big step forward,” she added.
The study was inspired by the observation that few patients with chronic asthma were being admitted to the hospital during the first months of the pandemic. The findings can confirm that this trend is due to the use of corticosteroid inhalers, preventing more severe respiratory effects. If confirmed, the discovery could save countless lives.
‘Vaccine programs are really exciting, but we know that it will take some time to reach everyone around the world, “said Bafadhel.” I am excited that a relatively safe, widely available and well-studied drug, such as an inhaled steroid, could have an impact on the pressures we are experiencing during the pandemic. “
Do you want to know how else you can reduce your serious COVID risk? Read on for more ways to keep the virus under control and to learn more about your potential risk level, check If you have this common habit, your COVID symptoms will be worse.
1
Colchicine
Budesonide is not the only drug already on the market that can fight COVID. According to a recent Canadian study, which has not yet been evaluated by peers, an anti-inflammatory drug against gout called colchicine could also significantly reduce the rate of hospitalization and death from the new coronavirus.
The researchers insist that, in addition to these benefits, colchicine is also inexpensive, administered orally and has few known side effects. In addition, the team reported that the treatment group had fewer cases of pneumonia and demonstrated a reduced need for supplemental oxygen. And for more drugs that can help prevent serious cases, check out This drug can reduce your risk of dying from COVID, experts say.
two
Aspirin
New research also reveals that those who take a daily dose of aspirin may have better results from COVID than those who do not.
An October study in the journal Anesthesia and Analgesia reviewed the medical records of more than 400 coronavirus patients hospitalized from March to July. Among these patients, those who took a low daily dose of aspirin were found to be 43 percent less likely to be transferred to the intensive care unit (ICU) and 44 percent less likely to be placed on a ventilator. Finally, these same patients were also 47% less likely to die from COVID than hospitalized patients who did not take aspirin daily. And to avoid getting the virus in the first place, find out where you’re most likely to get COVID now, says a new study.
3
Xlear nasal spray
According to a December study that has not yet been reviewed by experts, a simple nasal spray can have a profound effect on the new coronavirus. Through in vitro tests, the researchers found that Xlear Sinus Care can help neutralize COVID-19: it was able to significantly reduce the amount of active COVID virus after just 25 minutes.
The ingredients in the spray include xylitol – a chemical compound often used as a sweetener – as well as 0.2% grapefruit seed extract (GSE) and 0.85% saline. “Combination therapy with GSE and xylitol may prevent the spread of viral respiratory infections not only for SARS-CoV-2, but also for future H1N1 or other viral epidemics,” wrote the study’s authors. “GSE significantly reduces viral load, while xylitol prevents the virus from binding to the central protein in the cell wall.” And for more COVID news sent straight to your inbox, subscribe to our daily newsletter.
4
Anticoagulants
Blood clots are a common occurrence with COVID, affecting approximately one third of critically ill patients, according to a January meta-analysis published in the journal. Medical Hypotheses. And that is why anticoagulants may be the answer. In a February 2021 study published in The BMJ, the researchers examined data from 4,297 patients with COVID from the United States Department of Veterans Affairs, with an average age of 68 years. They found that patients with COVID who received anticoagulants 24 hours after being admitted to the hospital had their risk of death reduced by 34 percent compared with individuals who did not receive the medication.
While more research is needed, the study’s authors say their findings “provide strong real-world evidence to support guidelines that recommend the use of prophylactic anticoagulation as an initial treatment for patients with COVID-19 on hospital admission.” And to learn more about what can reduce your COVID risk, see These 3 vitamins can save you from severe COVID, study findings